'Laws Of Chemistry' Trump PTAB, Illumina Rival Tells Jury

By Hannah Albarazi (November 17, 2021, 10:17 PM EST) -- The chief scientific officer of Chinese-owned DNA sequencing company Complete Genomics testified in a California federal jury trial Wednesday over rival Illumina's $25 million infringement suit that Federal Circuit and Patent Trial and Appeal Board judges wrongly upheld Illumina's patents, saying that "a thousand judges cannot overrule the laws of chemistry."

Rade Drmanac, who co-founded Complete Genomics and remained as its chief scientist after BGI Genomics Co. Ltd. acquired it in 2013, told the jury that California-based Illumina Inc. and Illumina Cambridge Ltd.'s DNA sequencing patents were "so obvious."

Drmanac testified that the decision to uphold Illumina's patents resulted from "scientifically...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!